FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022302632> ?p ?o ?g. }

• W2022302632 abstract "At the intervention for cardiovascular disease (CVD), albuminuria is a new pivotal target. Calcium channel blocker (CCB) is one of the most expected agents. Currently CCBs have been classified by delivery system, half-life and channel types. We tested anti-albuminuric effect among 4 types of CCBs.Subjects were 50 hypertensives (SBP/DBP 164.7±17.1/92.3±12.2mmHg, s-Cr 0.81±0.37mg/dl, urinary albumin excretion (UAE) 69.4 (33.5-142.6) mg/gCr). Four CCBs were administered in a crossover setting: nifedipine CR, a long biological half-life L type by controlled release; cilnidipine, an N/L type; efonidipine, a T/L type; and amlodipine, a long biological half-life L type.Comparable BP reductions were obtained. UAE at endpoints ware as follows (mg/gCr, *P<0.01): nifedipine CR 30.8 (17.3-81.1),* cilnidipine 33.9 (18.0-67.7),* efonidipine 51.0 (21.2-129.8), amlodipine 40.6 (18.7-94.7). By all agents, significant augmentations were observed in PRA, angiotensin I and angiotensin II (AngII). AngII at cilnidipine was significantly lower than that at amlodipine. PAC at cilnidipine and efonidipine was significantly lower than that at amlodipine. Nifedipine CR significantly reduced ANP concentration.It is revealed that only nifedipine CR and cilnidipine could reduce albuminuria statistically. Thus, it is suggested that the 2 CCBs might be favorable for organ protection in hypertensives." @default.
• W2022302632 created "2016-06-24" @default.
• W2022302632 creator A5005161532 @default.
• W2022302632 creator A5007474320 @default.
• W2022302632 creator A5027547639 @default.
• W2022302632 creator A5036811980 @default.
• W2022302632 creator A5036987592 @default.
• W2022302632 creator A5064023022 @default.
• W2022302632 creator A5064950475 @default.
• W2022302632 creator A5076826232 @default.
• W2022302632 creator A5084449197 @default.
• W2022302632 creator A5089510043 @default.
• W2022302632 date "2013-06-01" @default.
• W2022302632 modified "2023-09-27" @default.
• W2022302632 title "A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers" @default.
• W2022302632 cites W1845712656 @default.
• W2022302632 cites W1964830572 @default.
• W2022302632 cites W1974911554 @default.
• W2022302632 cites W1979072447 @default.
• W2022302632 cites W1985957556 @default.
• W2022302632 cites W1991926280 @default.
• W2022302632 cites W1993280443 @default.
• W2022302632 cites W2001823655 @default.
• W2022302632 cites W2002390367 @default.
• W2022302632 cites W2003165431 @default.
• W2022302632 cites W2008980032 @default.
• W2022302632 cites W2010032346 @default.
• W2022302632 cites W2015183732 @default.
• W2022302632 cites W2021233494 @default.
• W2022302632 cites W2022724650 @default.
• W2022302632 cites W2025775657 @default.
• W2022302632 cites W2026762197 @default.
• W2022302632 cites W2036540809 @default.
• W2022302632 cites W2042689611 @default.
• W2022302632 cites W2047463598 @default.
• W2022302632 cites W2053559739 @default.
• W2022302632 cites W2054913321 @default.
• W2022302632 cites W2056976690 @default.
• W2022302632 cites W2065857917 @default.
• W2022302632 cites W2068816298 @default.
• W2022302632 cites W2081198685 @default.
• W2022302632 cites W2085979656 @default.
• W2022302632 cites W2087317768 @default.
• W2022302632 cites W2089970906 @default.
• W2022302632 cites W2093962101 @default.
• W2022302632 cites W2093988720 @default.
• W2022302632 cites W2096875294 @default.
• W2022302632 cites W2104005164 @default.
• W2022302632 cites W2106344589 @default.
• W2022302632 cites W2112520390 @default.
• W2022302632 cites W2120309176 @default.
• W2022302632 cites W2123119084 @default.
• W2022302632 cites W2148719618 @default.
• W2022302632 cites W2161902880 @default.
• W2022302632 cites W2171595257 @default.
• W2022302632 cites W2225667633 @default.
• W2022302632 cites W2330539553 @default.
• W2022302632 cites W2529012027 @default.
• W2022302632 cites W2912991414 @default.
• W2022302632 cites W3000563840 @default.
• W2022302632 doi "https://doi.org/10.1016/j.ijcard.2011.10.133" @default.
• W2022302632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22112682" @default.
• W2022302632 hasPublicationYear "2013" @default.
• W2022302632 type Work @default.
• W2022302632 sameAs 2022302632 @default.
• W2022302632 citedByCount "6" @default.
• W2022302632 countsByYear W20223026322013 @default.
• W2022302632 countsByYear W20223026322014 @default.
• W2022302632 countsByYear W20223026322015 @default.
• W2022302632 countsByYear W20223026322016 @default.
• W2022302632 countsByYear W20223026322017 @default.
• W2022302632 countsByYear W20223026322020 @default.
• W2022302632 crossrefType "journal-article" @default.
• W2022302632 hasAuthorship W2022302632A5005161532 @default.
• W2022302632 hasAuthorship W2022302632A5007474320 @default.
• W2022302632 hasAuthorship W2022302632A5027547639 @default.
• W2022302632 hasAuthorship W2022302632A5036811980 @default.
• W2022302632 hasAuthorship W2022302632A5036987592 @default.
• W2022302632 hasAuthorship W2022302632A5064023022 @default.
• W2022302632 hasAuthorship W2022302632A5064950475 @default.
• W2022302632 hasAuthorship W2022302632A5076826232 @default.
• W2022302632 hasAuthorship W2022302632A5084449197 @default.
• W2022302632 hasAuthorship W2022302632A5089510043 @default.
• W2022302632 hasBestOaLocation W20223026322 @default.
• W2022302632 hasConcept C10146269 @default.
• W2022302632 hasConcept C126322002 @default.
• W2022302632 hasConcept C126894567 @default.
• W2022302632 hasConcept C142724271 @default.
• W2022302632 hasConcept C204787440 @default.
• W2022302632 hasConcept C27081682 @default.
• W2022302632 hasConcept C2776174234 @default.
• W2022302632 hasConcept C2779066535 @default.
• W2022302632 hasConcept C2779134260 @default.
• W2022302632 hasConcept C2779646130 @default.
• W2022302632 hasConcept C2780356492 @default.
• W2022302632 hasConcept C519063684 @default.
• W2022302632 hasConcept C71924100 @default.
• W2022302632 hasConcept C84393581 @default.
• W2022302632 hasConcept C85520022 @default.
• W2022302632 hasConcept C87813604 @default.

• next